Corcept Therapeutics Incorporated
General ticker "CORT" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $5.9B
Corcept Therapeutics Incorporated follows the US Stock Market performance with the rate: 61.3%.
Estimated limits based on current volatility of 2.3%: low 49.72$, high 52.08$
Factors to consider:
- Current price 39.3% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [21.73$, 37.46$]
- 2024-12-30 to 2025-12-30 estimated range: [26.47$, 43.68$]
Financial Metrics affecting the CORT estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 0.95
- Positive: Operating profit margin, % of 22.24 > 19.51
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.59 > 7.10
- Positive: 2.35 < Operating cash flow per share per price, % of 4.33
Short-term CORT quotes
Long-term CORT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $365.98MM | $401.86MM | $482.38MM |
| Operating Expenses | $241.50MM | $289.22MM | $375.09MM |
| Operating Income | $124.48MM | $112.63MM | $107.28MM |
| Non-Operating Income | $0.53MM | $3.56MM | $17.27MM |
| R&D Expense | $113.86MM | $130.99MM | $184.35MM |
| Income(Loss) | $125.01MM | $116.19MM | $124.56MM |
| Taxes | $12.49MM | $14.77MM | $18.42MM |
| Profit(Loss) | $112.51MM | $101.42MM | $106.14MM |
| Stockholders Equity | $375.81MM | $501.84MM | $506.70MM |
| Inventory | $17.95MM | $17.03MM | $7.73MM |
| Assets | $423.76MM | $583.43MM | $621.52MM |
| Operating Cash Flow | $167.89MM | $120.32MM | $127.04MM |
| Capital expenditure | $0.47MM | $0.41MM | $0.14MM |
| Investing Cash Flow | $136.13MM | $-114.33MM | $90.91MM |
| Financing Cash Flow | $-302.59MM | $-17.28MM | $-148.72MM |
| Earnings Per Share* | $0.97 | $0.95 | $1.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.